Department of Clinical Biochemistry, Copenhagen University Hospital-Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Department of Cardiology, Copenhagen University Hospital-Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
J Med Case Rep. 2024 Sep 29;18(1):473. doi: 10.1186/s13256-024-04803-w.
Plasma levels of D-dimer are elevated in patients with thromboembolisms. Here we investigated the existence of interfering antibodies as a potential cause for elevated D-dimer levels.
A 42-year-old white Caucasian woman with a prior history of pulmonary embolism during her first pregnancy (treated with heparin therapy for 6 weeks postnatally) and hypothyroidism had a persistent elevated D-dimer without any clinical or ultrasound-based signs of thromboembolic conditions during her second pregnancy. We obtained informed consent and plasma was obtained from the patient. D-dimer levels were measured using two different assays. We also tested for the presence of rheumatoid factor, performed dilution series, and finally used an antibody depletion strategy. The two D-dimer assays performed similarly. Using our antibody depletion technique, we observed that ~ 1/3 of the increased plasma levels of D-dimer may be attributed to interfering antibodies.
Our results identify interfering antibodies as a potential contributor to an increased D-dimer in this patient. Our case highlights the potential of heterophilic interference for increased D-dimer and provides a procedure to determine this analytically.
患有血栓栓塞症的患者血浆 D-二聚体水平升高。在这里,我们研究了干扰抗体的存在是否是导致 D-二聚体水平升高的潜在原因。
一位 42 岁的白人高加索妇女,第一次怀孕时患有肺栓塞(产后用肝素治疗 6 周)和甲状腺功能减退症,第二次怀孕时 D-二聚体持续升高,无血栓栓塞疾病的临床或超声迹象。我们获得了知情同意,并从患者身上获得了血浆。使用两种不同的检测方法测量了 D-二聚体水平。我们还检测了类风湿因子的存在,进行了稀释系列,最后使用了抗体耗竭策略。两种 D-二聚体检测方法的表现相似。使用我们的抗体耗竭技术,我们观察到约 1/3 的 D-二聚体血浆水平升高可能归因于干扰抗体。
我们的结果表明,干扰抗体是导致该患者 D-二聚体升高的潜在原因之一。我们的病例强调了异嗜性干扰导致 D-二聚体升高的可能性,并提供了一种确定这种分析性干扰的方法。